BC FINANCE
Saved by @SteveeRogerr

1/ THREAD: Long ImmunoPrecise Antibodies (IPA- Nasdaq)
$IPA is my largest holding since mid-2020, I haven't sold a share

This thread is just the peak of the iceberg as IPA has made such progress that highlighting all on a thread isn't possible, apologize for lots of omissions

 2/ IPA is composed of 2 businesses:

The CRO (Contract Research Organization) and Talem Therapeutics.

Both the CRO and Talem are on fire. The CRO is growing at +50% with GM of 60% and Talem (drug discovery company) has several programs with some about to start Phase 1.
3/ Current Market CAP 315MCAD /250M USD
SO: ~16M
Rev run rate ~20M CAD- Growth 50%
Cash: 16M CAD
4/ Let’s start with the CRO. In the antibodies space, IPA is the ONLY CRO that offers a complete end-to-end service from concept to clinical trials
5/CRO's revenues are growing at 50%, with 60% gross margins (the CRO industry has ~12%margins), IPA has more than 70% of the top 20 pharma as clients, more than 500 total clients, EBITDA positive, $16m in cash and run rate revenues of ~ $20M for this fiscal year
6/ IPA's CRO faced an evolution with the arrival of Dr Bath as CEO where it transitioned from the low-value diagnostic market to the high-value therapeutic market, IPA managed to do that with two transformative acquisitions: UPE and Modiquest and the incorporation of a Top team
7/ IPA CRO is able to have ~60% margins as it is the only CRO in the antibodies space that supports pre-clinical drug discovery from concept to IND enabling studies, so IPA's clients don't need to leave IPA until their programs are well advanced & avoid the transport of materials
8/ As of today the CRO managed to onboard 70% of the top 20 pharma companies as clients (and growing) and has already had 2 quarters of Positive (adjusted) EBITDA. Clients start with small projects and with experience give larger projects to IPA (more projects with higher value)
9) How big is the antibody therapeutics market, see below. I expect IPA to capture growth rates well above the industry ones. The CEO started at IPA by bringing a top-class team, developed the strategy of the CRO and launched Talem, which is IPA’s drug discovery company
10/ To finalize the CRO, I expect revenues to grow no less than 30% PA (currently at +50%) maintain margins around 60% & operational leverage will be clear as extra growth should go to the bottom line, (unless it is used to fund Talem). The current MC supports the CRO alone
11/ Let me introduce TALEM Therapeutics.

Talem is IPA'S subsidiary focused on the discovery and development of next-generation fully human, monoclonal therapeutic antibodies. Talem is designed to take ownership stakes during the antibody’s discovery and development states.
12/Talem was founded in 2019 and an internal pipeline was created. TALEM is disease agnostic and uses the CRO's services at cost.

Talem is the most exciting component of IPA. Programs in the pre-clinical pipeline range from immuno-oncology to COVID-19
13/ I want to show the huge evolution on Talem's pipeline (see both slides below), in only a few months TALEM pipeline moved from 9 programs with only one partner to more than 16 today with several partners and some are about to present pre-clinical trials data, ready to phase 1
14/ It is hard to describe how valuable that pipeline can become, and how impressive it is that Talem's programs have been predominantly funded by the CRO.

I will focus on one now, to show the quality of the company: The COVID Program
15/ IPA's COVID program started in Jan 2020 with the aim to find a therapeutic that is efficacious for the current strains (of the time) & future viral mutations. Remember Regeneron antibody treatment with 1 antibody? IPA is in pre-clinical trials with a cocktail of 4 antibodies
16/ This cocktail is called the Polytope, I encourage to read the explanation in the below link to start understanding the science. Bottom line, if the Polytope works it would be efficacious with future mutations, pre-clinical trials about to be released

https://t.co/7e5MyOt1Eb
17/ IPA’s is also engaged in vaccines (currently in trials-see below) & in the last 5 months has initiated various partnerships, collaborations, etc, all of which are highlighted on the below slide:

Please see for your self the quality of the partners IPA has engaged since SEP
18/ I have left so much out, and I deliberately made this thread non-scientific, however below I include some sources where you can get a grasp of the science, and they are a must-watch.

1: https://t.co/evkgcuhW1f

2: https://t.co/xeLLM13wMv

3:https://t.co/olpUVw8x1G
19/ On the last conference the CEO mentioned the 1st commercial sale of internal Talem antibodies and announced material revenue from license deals within the next 2 quarters. This validates Talem in a serious way
20/ The industry is after the next-generation sequencing which is designing cocktails by screening ag libraries the companies build, while not apple to apple IPA can be at some extent compared to Abcellera (ABCL has a transgenic animal, IPA does not) but ABCL is priced 50x IPA
21/ We get Talem's potential relatively for free as the current market cap supports only the CRO. IPA just listed on NASDAQ and remains extremely under the radar, I don't think this will be the case for long, as IPA has hired a top IR firm & eventually institutions will become SH
22/ As usual some programs will not work, but some will and many companies with programs in Phase 1 trials already have multi-billion $ valuations, it is hard to not see the potential and most importantly the "OPTIONALITY" of IPA
23/ IPA did a prospectus where they can raise up to $150M, I would like IPA to do a PP in order to bring institutions on board and use that capital either for acquisitions for the CRO or clearly for Talem. With the Nasdaq listing, this makes total sense.
24/ An illustration of what is to come: Yasmina Noubia Abdiche, IPA's Chief Scientific Officer latest patents:

https://t.co/iAAJWJxbe0
END/ As mentioned this thread covers only a portion of what $IPA is, management is outstanding and I am truly excited for IPA's future. DYODD

Find below the latest deck:

https://t.co/r42pXenMX6

More from Finance

Steve
Steve
@braidedmanga
Ivor Cummins has been wrong (or lying) almost entirely throughout this pandemic and got paid handsomly for it.

He has been wrong (or lying) so often that it will be nearly impossible for me to track every grift, lie, deceit, manipulation he has pulled. I will use...


... other sources who have been trying to shine on light on this grifter (as I have tried to do, time and again:


Example #1: "Still not seeing Sweden signal versus Denmark really"... There it was (Images attached).
19 to 80 is an over 300% difference.

Tweet: https://t.co/36FnYnsRT9


Example #2 - "Yes, I'm comparing the Noridcs / No, you cannot compare the Nordics."

I wonder why...

Tweets: https://t.co/XLfoX4rpck / https://t.co/vjE1ctLU5x


Example #3 - "I'm only looking at what makes the data fit in my favour" a.k.a moving the goalposts.

Tweets: https://t.co/vcDpTu3qyj / https://t.co/CA3N6hC2Lq
FINANCE , ALL
Tren Griffin
Tren Griffin
@trengriffin
1/ Peter Bevelin, who has written books like “Seeking Wisdom: From Darwin to Munger,” provided me with a rough transcript of the Charlie Munger talk from yesterday. I did some clean up and editing and focus on points I didn’t make in my tweets yesterday.

2/ “All successful investment involves trying to get into something where it's worth more than you're paying. That's what successful investment is. There are a lot of different ways to find something worth more than you're paying. You can do what Sequoia does [e.g, in VC]."

3/ “Good investing requires a weird combination of patience and aggression and not many people have it. It also requires a big amount of self-awareness about how much you know and how much you don't know. You have to know the edge of your own competency."

4/ "A lot of brilliant people are no good knowing the edge of their own competency. They think they're way smarter than they are. Of course, that's dangerous and causes trouble.” Charlie Munger

5/ “When I was young, there was practically nobody involved in investing and they weren't very smart. Now almost everybody's smart. A good proportion of the people in investing are sucked into finance by the money. That's an important development. I don't welcome it at all."
FINANCE
Advertisement
Dave Nemetz
Dave Nemetz
@davenemetz
1/ A lot of people ask me how Bleacher Report found our first writers when we were tiny and had no funding.

So here's a thread on all the things we tried, what worked best, and lessons on growing a community from scratch:

2/ When we first started B/R, all the articles were written by my co-founders, our friends, and me.

This led to some hilariously bad takes. Like this article where I panned the SF Giants for drafting future World Series MVP Madison Bumgarner.

3/ When we were ready to start building our community, we started with word of mouth. We drafted an email pitching our concept. It went out to everyone we knew, asking them to share it with anyone who would be interested.

This got us maybe a few dozen signups.

From the email:


4/ With only a handful of members, we needed to make the community feel more active.

So we faked it til we made it.

Our team created multiple accounts and posted using different fake names. This created the sense of more activity and encouraged new members to join in.

5/ Later, I learned that the founders of Reddit did the same thing early on.

Sometimes the solution to the "chicken and the egg" problem of building community is to create the illusion of more chickens (or
CULTURE , FINANCE
Neil Thomas \u725b\u7287
Neil Thomas 牛犇...
@neilthomas123
THREAD: Who are the rising stars of Chinese elite politics in the central Party-State bureaucracy?

For @MacroPoloChina I analyzed last year's ministerial-level promotions to posts in Beijing

TLDR: Ties to Xi Jinping—or a Xi ally—are very helpful! (1/14)

https://t.co/kO2A0Efyq2


Seven politicians were promoted to ministerial-level positions in central Party agencies last year

All are likely to feature on the next Central Committee selected at the 2022 Party Congress

Some could make the CCP's elite 25-person Politburo (2/14)

https://t.co/kO2A0Efyq2


Likeliest for the Politburo is Meng Xiangfeng, new Executive Deputy Director of the CCP General Office

He would replace Xi ally Ding Xuexiang as CCP chief-of-staff if Ding is promoted further in 2022

Meng worked under Xi allies Cai Qi in Hangzhou and Chen Xi in Liaoning (3/14)


Less likely for the Politburo but still important is Jiang Jinquan, new Director of the CCP Policy Research Office

He replaces 5th-ranked leader Wang Huning who led the Party's brains trust for 18 years

Wang remains prominent and will be <68 in 2022, so he'll stay around (4/14)


Other notable central Party promotions include Li Shulei and Liang Yanshun, who both assisted Xi when he led the Central Party School from 2007-2012

Li is a political conservative who is said to be quite close with Xi, even drafting his 2014 speech on culture and art (5/14)
FINANCE
Carrie
Carrie
@life_is_art___
@JSG_54 I’d like to make a list of which ones and when they were put on the payroll from the attorneys. Also, others like Caleb Alexander and Tim Munson. Anyone that has had their hand in policy or publicly demonized pain meds and then profited off of litigation, get em on the list.

Here’s #ArtVanZee

#AnnaLembke

#DaneshMazloomdoost

#AndrewKolodny
FINANCE

You May Also Like

Indian Quant
Indian Quant
@indian_quant
Nano Course On Python For Trading
==========================
Module 1

Python makes it very easy to analyze and visualize time series data when you’re a beginner. It's easier when you don't have to install python on your PC (that's why it's a nano course, you'll learn python...

... on the go). You will not be required to install python in your PC but you will be using an amazing python editor, Google Colab Visit https://t.co/EZt0agsdlV

This course is for anyone out there who is confused, frustrated, and just wants this python/finance thing to work!

In Module 1 of this Nano course, we will learn about :

# Using Google Colab
# Importing libraries
# Making a Random Time Series of Black Field Research Stock (fictional)

# Using Google Colab

Intro link is here on YT: https://t.co/MqMSDBaQri

Create a new Notebook at https://t.co/EZt0agsdlV and name it AnythingOfYourChoice.ipynb

You got your notebook ready and now the game is on!
You can add code in these cells and add as many cells as you want

# Importing Libraries

Imports are pretty standard, with a few exceptions.
For the most part, you can import your libraries by running the import.
Type this in the first cell you see. You need not worry about what each of these does, we will understand it later.
PYTHON , TRADE PYTHON , PYTHON TRADING
Stephen Bush
Stephen Bush
@stephenkb
Some quick thoughts on Sam Gyimah's resignation after conversations with various Conservative MPs: 1) the chances of a second referendum are a lot higher than I thought:

2) At this point, if you are a young and ambitious Tory MP it is now so overwhelmingly in your interest to vote against the withdrawal agreement. V v hard to see how Julian Smith can cap rebellion at under 100:

3) Really just to reiterate 1) Gyimah is the kind of "No, never gonna rebel" vaguely pro-EU Tory you'd need to get on side to outweigh Labour Leavers and Real Concerners.
POLITICS
Advertisement
History Under Your Feet
History Under Your Fee...
@HUFToday
#TodayInHistory Ram Prasad Bismil,Ashfaqullah Khan and Roshan Singh are hanged in 1927, as they give up their life for the cause of freedom and inspire many a revolutionary. #LestWeForget


Shahjahanpur was a hub of revolution during the freedom struggle. Most of the revolutioaries in the North, were from this town. And among them, the most famous were two friends, whom destiny would bring together- Ram Prasad Bismil and Ashfaqullah Khan.

Ashfaqullah Khan was born at the turn of the 20th century on October 22, while Bismil was born 3 years earlier on June 11, in the same town. Both of them were excellent writers in Urdu and Hindi.

Both of them would come together under the Hindustan Republican Association, not to mention the fact that Ashfaq was an admirer of Bismil’s poetry, and became close friends with him on that account.

And both these men were hanged on the same date, December 19, 1927 for their involvement in the Kakori event. Two men from different religions, different backgrounds, yet destiny would bring them together.
HISTORY
Reagan Gomez
Reagan Gomez
@ReaganGomez
Black movie goers know which movies are for us and which films aren’t. We really don’t like our stories being made into films that center (and humanize) people that hate us. The filmmakers/studio know that by naming the film “The Green Book”, black movie goers...

...are going to be expecting a story about black people trying to safely navigate the country (real history) and instead will get a white savior film. Like folks went to see Detroit thinking it was about the riots...

Anywhoo, I know Mahershela is fantastic in it. He was the best thing about the trailer. As rich as the history behind the creation of ‘The Green Book’ is/was, as amazing as Dr. Don Shirley’s story is, WHY is this film about a random, racist driver and his family?

This feeds into the ignorant anti-Black American stereotype of “Black Americans don’t have any culture/history/mythology” or whatever. That our stories are still both being used while simultaneously erased in 2018 is wild to me. It’s gonna clean up come award season. 🤦🏾‍♀️

And now, if black filmmakers WANTED to make a film about The Greenbook, guess what it can’t be called🙃. Just like if someone wanted to make a film about the actual Detroit riots, guess what it can’t be called? Then those filmmakers would run into...
CULTURE
Dr. Thomas Binder, MD
Dr. Thomas Binder, MD
@Thomas_Binder
1/12

RT-PCR corona (test) scam

Symptomatic people are tested for one and only one respiratory virus. This means that other acute respiratory infections are reclassified as


2/12

It is tested exquisitely with a hypersensitive non-specific RT-PCR test / Ct >35 (>30 is nonsense, >35 is madness), without considering Ct and clinical context. This means that more acute respiratory infections are reclassified as


3/12

The Drosten RT-PCR test is fabricated in a way that each country and laboratory perform it differently at too high Ct and that the high rate of false positives increases massively due to cross-reaction with other (corona) viruses in the "flu


4/12

Even asymptomatic, previously called healthy, people are tested (en masse) in this way, although there is no epidemiologically relevant asymptomatic transmission. This means that even healthy people are declared as COVID


5/12

Deaths within 28 days after a positive RT-PCR test from whatever cause are designated as deaths WITH COVID. This means that other causes of death are reclassified as
CATEGORY C19